These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3891230)

  • 21. Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis.
    Puskarich MA; Runyon MS; Trzeciak S; Kline JA; Jones AE
    J Clin Pharmacol; 2009 Jul; 49(7):758-67. PubMed ID: 19417124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
    Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
    JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon.
    Opie LH; Bruyneel K; Owen P
    Circulation; 1975 Jul; 52(1):49-57. PubMed ID: 236843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin (GIK) improves central mixed and hepatic venous oxygenation in clinical cardiac surgery.
    Lindholm L; Bengtsson A; Hansdottir V; Westerlind A; Jeppsson A
    Scand Cardiovasc J; 2001 Oct; 35(5):347-52. PubMed ID: 11771827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis.
    Fan Y; Zhang AM; Xiao YB; Weng YG; Hetzer R
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):192-9. PubMed ID: 21075642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock].
    Tao Y; Jingyi W; Xiaogan J; Weihua L; Xiaoju J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Nov; 27(11):885-9. PubMed ID: 27132454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
    Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose-insulin-potassium infusion for the treatment of acute aluminum phosphide poisoning: an open-label pilot study.
    Pannu AK; Bhalla A; Gantala J; Sharma N; Kumar S; Dhibar DP
    Clin Toxicol (Phila); 2020 Oct; 58(10):1004-1009. PubMed ID: 32129101
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
    Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
    Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of hypertrophic heart myocardial glycogen to GIK and hypovolemic shock.
    Wittnich C; Trudel JL; Chiu RC
    Circ Shock; 1986; 19(4):423-8. PubMed ID: 2943528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-dependent diabetes during the peri-operative period. An assessment of continuous glucose-insulin-potassium infusion, and traditional treatment.
    Thomas DJ; Platt HS; Alberti KG
    Anaesthesia; 1984 Jul; 39(7):629-37. PubMed ID: 6380335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-insulin-potassium correlates with hemodynamic improvement in patients with septic myocardial dysfunction.
    Kim WY; Baek MS; Kim YS; Seo J; Huh JW; Lim CM; Koh Y; Hong SB
    J Thorac Dis; 2016 Dec; 8(12):3648-3657. PubMed ID: 28149560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of levosimendan on hemodynamics and cardiac function in patients with septic shock].
    Fang M; Dong S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct; 26(10):692-6. PubMed ID: 25315937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial.
    Selker HP; Harris WS; Rackley CE; Marsh JB; Ruthazer R; Beshansky JR; Rashba EJ; Peter I; Opie LH
    Am Heart J; 2016 Aug; 178():168-75. PubMed ID: 27502865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II.
    Rasoul S; Ottervanger JP; Timmer JR; Svilaas T; Henriques JP; Dambrink JH; van der Horst IC; Zijlstra F
    Int J Cardiol; 2007 Oct; 122(1):52-5. PubMed ID: 17223212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protective effect of glucose-insulin-potassium on the response to atrial pacing.
    Chiong MA; West R; Parker JO
    Circulation; 1976 Jul; 54(1):37-46. PubMed ID: 1277428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preconditioning with glucose-insulin-potassium solution and restoration of myocardial function during coronary surgery.
    Jovic M; Gradinac S; Lausevic-Vuk L; Nezic D; Stevanovic P; Milojevic P; Djukanovic B
    Gen Physiol Biophys; 2009; 28 Spec No():262-70. PubMed ID: 19893109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions.
    Lazar HL; Zhang X; Rivers S; Bernard S; Shemin RJ
    Ann Thorac Surg; 1995 Aug; 60(2):411-6. PubMed ID: 7646105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epinephrine as an inotropic agent in septic shock: a dose-profile analysis.
    Moran JL; O'Fathartaigh MS; Peisach AR; Chapman MJ; Leppard P
    Crit Care Med; 1993 Jan; 21(1):70-7. PubMed ID: 8420733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.